LEADERSHIP IN NANOPHARMACEUTICALS Trademark

Pharmaceutical preparations for use in the diagnosis and prognosis of oncological diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of pre-cancerous diseases or disorders; pharmaceutical preparations for use in the diagnosis and prognosis of malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of benign cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations, namely, drug delivery systems that contain compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain nanometer scale or nanometer size compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain polymer and/or lipid based compounds for controlled release of a wide range of pharmaceuticals; pharmaceutical preparations for use in the diagnosis and prognosis of oncological diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of pre-cancerous diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of benign cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis and prognosis of malignant cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical

diagnostic and prognostic preparations for clinical or medical laboratory use; diagnostic and prognostic reagents for identifying a disease or disorder and/or the progression of a disease or disorder